Alex R.  Thurman net worth and biography

Alex Thurman Biography and Net Worth

CFO of Glaukos
Mr. Thurman has served as our senior vice president, chief financial officer since April 2022. He previously served as our vice president, finance from December 2016 to March 2022, and before that as our vice president, global tax and administration when he joined Glaukos in July 2016 through November 2016. Mr. Thurman has been instrumental in building out the company’s finance organization by overseeing significant growth of the finance team, navigating the transition to SOX compliance, instituting the financial infrastructure to serve 16 new international direct sales markets and leading the integration of the company’s new ERP system from a financial perspective. Prior to Glaukos, he held increasingly responsible financial and tax leadership positions over 20 years at Allergan, Inc., Deloitte and Arthur Andersen. Mr. Thurman has a B.S. in Accounting and Master of Accountancy in Tax from Brigham Young University and received a CPA license (inactive) from the state of California.

What is Alex R. Thurman's net worth?

The estimated net worth of Alex R. Thurman is at least $7.30 million as of May 10th, 2024. Mr. Thurman owns 51,647 shares of Glaukos stock worth more than $7,304,952 as of November 21st. This net worth estimate does not reflect any other assets that Mr. Thurman may own. Additionally, Mr. Thurman receives a salary of $621,240.00 as CFO at Glaukos. Learn More about Alex R. Thurman's net worth.

How old is Alex R. Thurman?

Mr. Thurman is currently 54 years old. There are 5 older executives and no younger executives at Glaukos. The oldest executive at Glaukos is Ms. Jane E. Rady, Senior Vice President of Corporate Strategy & Business Development, who is 76 years old. Learn More on Alex R. Thurman's age.

What is Alex R. Thurman's salary?

As the CFO of Glaukos Co., Mr. Thurman earns $621,240.00 per year. There are 3 executives that earn more than Mr. Thurman. The highest earning executive at Glaukos is Mr. Joseph E. Gilliam, President & COO, who commands a salary of $1,180,000.00 per year. Learn More on Alex R. Thurman's salary.

How do I contact Alex R. Thurman?

The corporate mailing address for Mr. Thurman and other Glaukos executives is 229 AVENIDA FABRICANTE, SAN CLEMENTE CA, 92672. Glaukos can also be reached via phone at (949) 367-9600 and via email at [email protected]. Learn More on Alex R. Thurman's contact information.

Has Alex R. Thurman been buying or selling shares of Glaukos?

Alex R. Thurman has not been actively trading shares of Glaukos during the past quarter. Most recently, Alex R. Thurman sold 353 shares of the business's stock in a transaction on Friday, May 10th. The shares were sold at an average price of $110.51, for a transaction totalling $39,010.03. Following the completion of the sale, the chief financial officer now directly owns 51,647 shares of the company's stock, valued at $5,707,509.97. Learn More on Alex R. Thurman's trading history.

Who are Glaukos' active insiders?

Glaukos' insider roster includes Thomas Burns (CEO), Mark Foley (Director), Joseph Gilliam (CFO), Gilbert Kliman (Director), Marc Stapley (Director), Alex Thurman (CFO), and Aimee Weisner (Director). Learn More on Glaukos' active insiders.

Are insiders buying or selling shares of Glaukos?

During the last year, insiders at the medical instruments supplier sold shares 40 times. They sold a total of 554,220 shares worth more than $51,062,568.73. The most recent insider tranaction occured on October, 30th when COO Joseph E Gilliam sold 2,275 shares worth more than $316,156.75. Insiders at Glaukos own 6.4% of the company. Learn More about insider trades at Glaukos.

Information on this page was last updated on 10/30/2024.

Alex R. Thurman Insider Trading History at Glaukos

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2024Sell353$110.51$39,010.0351,647View SEC Filing Icon  
5/6/2024Sell90$110.26$9,923.4052,000View SEC Filing Icon  
5/2/2024Sell442$105.69$46,714.9852,090View SEC Filing Icon  
4/8/2024Sell1,372$100.54$137,940.8852,532View SEC Filing Icon  
4/4/2024Sell434$95.33$41,373.2254,166View SEC Filing Icon  
4/2/2024Sell474$90.37$42,835.3854,916View SEC Filing Icon  
2/7/2024Sell33$95.00$3,135.0054,585View SEC Filing Icon  
1/18/2024Sell583$90.54$52,784.8254,618View SEC Filing Icon  
12/21/2023Sell583$85.14$49,636.6255,242View SEC Filing Icon  
12/15/2023Sell1,270$79.80$101,346.0055,825View SEC Filing Icon  
See Full Table

Alex R. Thurman Buying and Selling Activity at Glaukos

This chart shows Alex R Thurman's buying and selling at Glaukos by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Glaukos Company Overview

Glaukos logo
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
Read More

Today's Range

Now: $141.44
Low: $139.87
High: $144.50

50 Day Range

MA: $131.75
Low: $121.58
High: $144.10

2 Week Range

Now: $141.44
Low: $59.22
High: $145.84

Volume

362,127 shs

Average Volume

573,926 shs

Market Capitalization

$7.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02